Ligand id: 2213

Name: atosiban

Structure and Physico-chemical Properties

2D Structure
No information available.
Summary of Clinical Use
Although not approved by the US FDA, atosiban is approved as a tocolytic agent by the EMA and other individual national approval agencies. Atosiban is used to delay birth in adult women who are 24 to 33 weeks pregnant, when they show signs that they may give birth pre-term (prematurely).
Mechanism Of Action and Pharmacodynamic Effects
Oxytocin acts via the oxytocin receptor to induce uterine contractions during parturition [3]. Oxytocin antagonists are used to suppress contractions in pre-term labor (tocolytic).